 |
|
|
|
|
SIO
 Happy New Year from the Society of Interventional Oncology! We are excited for year ahead and we hope you are too. Renew your membership today to secure your place among the most influential minds in this emerging field and to enjoy New Member Benefits!
Case Spotlight! The Society of Interventional Oncology is proud to announce the revival of Case of the Week, now called Case Spotlight! This is an opportunity for SIO members to share key findings from interesting patient cases within the interventional oncology community. Access to these biweekly cases and engagement in discussions will be available this month!
Conference Proceedings! SIO members in 2019 will have complimentary access to the recordings from SIO’s Annual Scientific meeting! This resource, valued at $200, will be available to all members via their SIO accounts and will be released each year following the conference.
Be sure to renew your membership before 31 January to restore your member benefits including discounted SIO 2019 registration, opportunities to apply for exclusive research grants, free CME, and other year-round benefits. Instructions for how to renew can be found here.
SIO
The Society of Interventional Oncology (SIO) invests in the success of the interventional oncology (IO) field by offering future IO professionals the opportunity to attend and engage in SIO's annual scientific meeting through the SIO Fellows & Resident-In Training scholarship. For 2019, we’ve expanded our program to include more interactive education, increased opportunities to connect with and learn from industry experts, and additional time to network with vendors and potential employers!
APPLY TODAY FOR THE CHANCE TO...
- Build a strong foundation for a successful career though our educational and scientific programs
- Receive high-quality, targeted Interventional Oncology education
- Network with esteemed experts from around the globe
- Take advantage of all that Boston has to offer in June
SCHOLARSHIP BENEFITS:
- Stipend for travel expenses ($200 local, $750 North America, and $1,000 international applicants)
- One year of complimentary membership to SIO
- Invitation to the IO Essentials Program taking place Friday, 7 June.*
*Recipients must be present for the entirety of the SIO 2019 Annual Meeting.
For more details and the application process, click here.
APPLY NOW!
SIO
Engage with the SIO 2019 program by nominating influential publications that you believe have made immediate clinical impact or that may influence the way patients are treated in the future. Publications can be nominated from basic science, translational or clinical research areas. Selected authors of the most influential articles will be invited to present their work during a plenary session at SIO 2019. Nominate Now!
| Promoted by |
|
|
|
 |
Techniques in Vascular and Interventional Radiology
The rapidly evolving field of interventional oncology comprises both diagnostic and therapeutic procedures for the treatment of various malignancies. With respect to the liver, the most commonly utilized therapeutic procedures include thermal tumor ablation and transarterial embolization. READ MORE
Hepatology International
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide and its incidence continues to rise. While cirrhosis underlies most cases of HCC, many molecular pathways are implicated in HCC carcinogenesis, including the TERT promoter mutation, Wnt/β-catenin, P53, Akt/mTOR, vascular endothelial growth factor receptor (VEGFR), and endothelial growth factor receptor (EGFR)/RAS/MAPK pathways. READ MORE
 |
|
Learn more about resorbable microspheres for targeted hypervascular tumor embolization
OptiSphere™ embolization spheres from Medtronic offer an alternative option for your patients.
Click here for more details. |
|
Radiology
Purpose: To evaluate the safety and efficacy of percutaneous transarterial embolization (PTAE) for the treatment of spontaneous soft-tissue hematomas (SSTHs) and identify variables predictive of short-term outcome. READ MORE
Journal of Gastrointestinal Oncology
BACKGROUND: Hepatocellular carcinoma (HCC) with portal vein invasion (PVI) has a poor prognosis with limited treatment options. Intra-arterial brachytherapy (IAB) and transarterial chemoembolization (TACE) yield local control but risk accelerating liver dysfunction. The outcomes, survival, and safety of selective liver-directed treatment are reported. METHODS: Thirty-seven consecutive patients with HCC and PVI treated between 2009 and 2015 were reviewed from a prospectively collected database. READ MORE |
|
European Radiology
OBJECTIVES: To investigate the feasibility of fetal phase-contrast (PC)-MR angiography of the descending aorta (AoD) using an MR-compatible Doppler ultrasound sensor (DUS) for fetal cardiac gating and to compare velocimetry with Doppler ultrasound measurements. METHODS: In this prospective study, 2D PC-MR angiography was performed in 12 human fetuses (mean gestational age 32.8 weeks) using an MR-compatible DUS for gating of the fetal heart at 1.5 T. READ MORE
Radiographics
Transarterial chemoembolization is the most common treatment for unresectable hepatocellular carcinomas (HCCs). However, when an HCC is located in the caudate lobe, many interventional radiologists are reluctant to perform chemoembolization and percutaneous ablation owing to the tumor's complex vascular supply and deep location. READ MORE |
| Cryotherapy is a minimally invasive treatment primarily for prostate, kidney and lung cancers as well as a palliative treatment for bone pain. It has been used since the 19th Century(see history below), but advancements continue to be made every year. Read more |
|
|
|
|
|
|
PLoS One
BACKGROUND: Population-based estimates of the incidence and prognosis of brain metastases at diagnosis of hepatocellular carcinoma (HCC) are lacking. The aim of this study was to characterize the incidence proportion and survival of newly diagnosed hepatocellular carcinoma with brain metastases (HCCBM). MATERIALS AND METHODS: Data from Surveillance, Epidemiology, and End Results (SEER) program between 2010 and 2014 was evaluated. READ MORE
Radiology
Purpose To develop and evaluate a dual-layer detector capable of acquiring intrinsically registered real-time fluoroscopic and nuclear images in the interventional radiology suite. Materials and Methods The dual-layer detector consists of an x-ray flat panel detector placed in front of a γ camera with cone beam collimator focused at the x-ray focal spot. READ MORE
World Journal of Gastroenterology
Various therapeutic modalities including radiofrequency ablation, cryoablation, microwave ablation, and irreversible electroporation have attracted attention as energy sources for effective locoregional treatment of hepatocellular carcinoma (HCC); these are accepted non-surgical treatments that provide excellent local tumor control and favorable survival. READ MORE |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063 |
